Clinical and genetic association, radiological findings and response to biological therapy in seven children from Qatar with non ‐bacterial osteomyelitis
ConclusionNon‐bacterial osteomyelitis may coexist with other autoinflammatory diseases. MRI remains a favorable diagnostic tool and genetic testing may have a limited role in selected cases. Infliximab and canakinumab are associated with variable outcomes, and 6‐week or less dosing intervals for both medications may be more effective.
Source: APLAR Journal of Rheumatology - Category: Rheumatology Authors: Taha Moussa, Venkatraman Bhat, Vishwanatha Kini, Basil M. Fathalla Tags: Original Article Source Type: research
More News: Anemia | Arthritis | Back Pain | Children | Chronic Pain | Genetics | Middle East Health | MRI Scan | Osteomyelitis | Pain | Pain Management | Qatar Health | Remicade | Rheumatology